tiprankstipranks
LENSAR (LNSR)
NASDAQ:LNSR
US Market

LENSAR (LNSR) Earnings Dates, Call Summary & Reports

78 Followers

Earnings Data

Report Date
May 07, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
Last Year’s EPS
-2.32
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 31, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a generally positive operational picture despite material near-term disruptions. Key strengths include strong recurring revenue growth (+15% YoY), robust procedure volume growth (+22% FY), rapid installed-base expansion (+48% ALLY YoY), positive adjusted EBITDA, and recovery of a $10M deposit plus concessions on acquisition liabilities. Primary challenges stem from the terminated acquisition and consequent distributor/customer uncertainty that depressed international system sales, elevated SG&A and merger-related expenses, and caused transient margin pressure. Management expects a multi-quarter re-acceleration as distributors reengage and commercial activities ramp, positioning the company to return to historical operating cadence.
Company Guidance
Management guided a gradual return to historical operating performance over the next several quarters of 2026 with three priorities—accelerate revenue growth (more system placements and higher utilization), maintain cost discipline, and enhance cash flow—and provided quantifiable targets: FY2026 gross margin expected in the 46%–49% range, no more than a 10% increase in cash‑based operating expenses (ex‑amortization and stock comp), and reengagement of OUS distributors to reaccelerate system sales. They noted key 2025 metrics underpinning the guidance: total revenue +9% YoY for 2025, Q4 revenue $16.0M (−4% YoY), recurring revenue +15% for 2025 (Q4 recurring $12.7M, annualizing >$50M; FY recurring $46.3M vs $40.1M in 2024), Q4 adjusted EBITDA $595K and positive adjusted EBITDA for the year, Q4 gross margin $6.9M (43%) and FY gross margin 46% (vs 48% in 2024), procedures +~20% in Q4 and +22% for FY to >206,000 (and +50% vs 2023), installed base >200 ALLY systems (up 48% YoY) and combined ALLY+LLS ~435 (up 13%), backlog of 13 systems, FY system sales 20 (vs 23 in 2024) with 12 US ALLY sales in Q4 and only 1 OUS, plus transaction impacts of $17.1M acquisition costs in 2025 (≈$14M unpaid at year‑end with ~$4.3M to be forgiven and $5M deferred to May 2027) and the $10M transaction deposit now released from escrow (Dec 31 cash reported at $18M; $10M liability to be eliminated in Q1 2026).
Recurring Revenue Growth and Stability
Recurring revenue grew 15% year-over-year for fiscal 2025 (full year recurring revenue $46.3M vs $40.1M in 2024). Recurring revenue in Q4 increased 17% to $12.7M and annualizes to over $50M, representing ~79% of Q4 revenue and providing a stable, higher-margin revenue base.
Strong Procedure Volume Expansion
Procedure volumes increased ~20% year-over-year in Q4 and grew 22% for full year 2025, surpassing 206,000 global procedures. Procedure volume since ALLY launch is up ~50% vs 2023, supporting recurring procedure revenue growth.
Rapid Installed Base and Market Share Gains
ALLY installed base grew to just over 200 systems (up ~48% year-over-year) and total combined installed base (ALLY + LLS) increased to ~435 systems (+13%). U.S. procedure market share rose from 14% to 23.4% as of year-end 2025 (≈+9.4 percentage points since launch).
System Utilization Outperformance
U.S. LENSAR systems perform on average 27% more procedures annually than the national average per laser, and ALLY accounts perform ~600 procedures/year on average, indicating strong utilization and higher recurring revenue per system.
Positive Adjusted EBITDA and Operating Cash Flow Signal
The company maintained a positive adjusted EBITDA for fiscal 2025, with Q4 adjusted EBITDA of $595K, indicating operating cash flow positive operations excluding working capital impacts despite disruption from the acquisition process.
Recovered Transaction Deposit and Reduced Acquisition Liabilities
Following mutual termination of the Alcon transaction, LENSAR recovered the $10M transaction deposit from escrow (now owned cash) and negotiated concessions that will eliminate ~$4.3M of unpaid advisor fees and defer ~$5M of remaining liability until May 2027, improving near-term liquidity.
Product Validation and Commercial Momentum
Management highlighted third-party validation of ALLY's technology during the acquisition process and noted that nearly 50% of Q4 system placements were with femto‑naive surgeons, demonstrating ability to expand the market and convert new customers.

LENSAR (LNSR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

LNSR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 2026
2026 (Q1)
- / -
-2.32
Mar 31, 2026
2025 (Q4)
0.18 / -0.12
-2.3294.83% (+2.20)
Nov 06, 2025
2025 (Q3)
- / -0.31
-0.13-138.46% (-0.18)
Aug 07, 2025
2025 (Q2)
-0.02 / -0.15
-0.7981.01% (+0.64)
May 08, 2025
2025 (Q1)
-0.15 / -2.32
-0.19-1121.05% (-2.13)
Feb 27, 2025
2024 (Q4)
-0.18 / -1.61
-0.35-360.00% (-1.26)
Nov 07, 2024
2024 (Q3)
-0.29 / -0.13
-0.2343.48% (+0.10)
Aug 08, 2024
2024 (Q2)
-0.30 / -0.79
-0.812.47% (+0.02)
May 09, 2024
2024 (Q1)
-0.29 / -0.19
-0.452.50% (+0.21)
Mar 04, 2024
2023 (Q4)
-0.22 / -0.35
-0.24-45.83% (-0.11)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

LNSR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 31, 2026
$5.87$5.96+1.53%
Nov 06, 2025
$12.52$11.44-8.63%
Aug 07, 2025
$13.03$12.84-1.46%
May 08, 2025
$13.83$13.81-0.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does LENSAR (LNSR) report earnings?
LENSAR (LNSR) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
    What is LENSAR (LNSR) earnings time?
    LENSAR (LNSR) earnings time is at May 07, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is LNSR EPS forecast?
          Currently, no data Available